1·OBJECTIVE: To evaluate the clinical efficacy and safty of lamivudine in treatment of patients with HBV infections.
目的：评价拉米夫定在乙型肝炎病毒（HBV）感染者治疗中的临床疗效和安全性。
2·CONCLUSION: Great importance should be attached to ADRs of lamivudine to ensure the safety of drug use in clinic.
结论：临床应重视拉米夫定的不良反应，以确保用药安全。
3·Objective To ascertain the distribution of HBV genotypes in Shandong province and its relationship with the antiviral effect of lamivudine.
目的确定乙型肝炎病毒（HBV）基因型在山东地区的分布及拉米夫定抗病毒疗效的影响。
4·Because lamivudine is in the same category of HIV therapies as another widely used drug, emtricitabine, its effectiveness is also compromised by entecavir, she says.
她说，因为拉米夫定同另一种广泛用于HIV治疗的药物恩曲他滨是同种类型的，它的效果也受到恩替卡韦的抑制。
5·Therefore, there is a need for a better definition of the potential role and limitations of lamivudine or similar therapies, used alone.
因此，有必要更好地界定拉米夫定单独使用或类似的疗法的潜在作用和局限性。